Navegando por Palavras-chave "Linfoma"
Agora exibindo 1 - 19 de 19
Resultados por página
Opções de Ordenação
- ItemSomente MetadadadosAnálise das taxas de sobrevida e fatores prognósticos no melanoma maligno da mucosa do trato aerodigestivo superior(Universidade Federal de São Paulo (UNIFESP), 1995) Rodrigues, Gerson da Silva [UNIFESP]; Andrews, Jorge de Moura [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)
- ItemSomente MetadadadosAnálise de custos e recursos utilizados no tratamento de episódios de neutropenia febril em pacientes com leucemias agudas e linfomas(Universidade Federal de São Paulo (UNIFESP), 2001) Costa, Vania Cristina Caniato [UNIFESP]nao tem
- ItemAcesso aberto (Open Access)Aplicação da ressonância magnética de corpo inteiro para o estadiamento e acompanhamento de pacientes com linfoma de Hodgkin na faixa etária infanto-juvenil: comparação entre diferentes sequências(Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, 2011-02-01) Nava, Daniel [UNIFESP]; Oliveira, Heverton Cesar de [UNIFESP]; Luisi, Flavio Augusto [UNIFESP]; Ximenes, Andrea Regina Da Silveira; Lederman, Henrique Manoel [UNIFESP]; Universidade Federal de São Paulo (UNIFESP); Clínica CentrusOBJECTIVE: To compare the performance of the T1, T2, STIR and DWIBS (diffusion-weighted whole-body imaging with background body signal suppression) sequences in the staging and follow-up of pediatric patients with Hodgkin's lymphoma in lymph node chains, parenchymal organs and bone marrow, and to evaluate interobserver agreement. MATERIALS AND METHODS: The authors studied 12 patients with confirmed diagnosis of Hodgkin's lymphoma. The patients were referred for whole body magnetic resonance imaging with T1-weighted, T2-weighted, STIR and DWIBS sequences. RESULTS: The number of lymph node sites characterized as affected by the disease on T1- and T2-weighted sequences showed similar results (8 sites for both sequences), but lower than DWIBS and STIR sequences (11 and 12 sites, respectively). The bone marrow involvement by lymphoma showed the same values for the T1-, T2-weighted and DWIBS sequences (17 lesions), higher than the value found on STIR (13 lesions). A high rate of interobserver agreement was observed as the four sequences were analyzed. CONCLUSION: STIR and DWIBS sequences detected the highest number of lymph node sites characterized as affected by the disease. Similar results were demonstrated by all the sequences in the evaluation of parenchymal organs and bone marrow. A high interobserver agreement was observed as the four sequences were analyzed.
- ItemSomente MetadadadosAplicação da ressonância magnética de corpo inteiro para o estadiamento e acompanhamento dos pacientes com linfoma de Hodgkin na faixa etária infanto-juvenil(Universidade Federal de São Paulo (UNIFESP), 2010) Nava, Daniel [UNIFESP]; Lederman, Henrique Manoel [UNIFESP]Objetivos: Comparar o desempenho das sequências T1, T2, STIR e DWIBS na identificação de sítios caracterizados como acometidos pelo linfoma de Hodgkin nas cadeias linfonodais, órgãos parenquimatosos e medula óssea e avaliar a concordância entre os examinadores na análise das diferentes sequências obtidas. Métodos: Foram estudados 12 pacientes com diagnóstico confirmado de linfoma de Hodgkin. Os pacientes foram encaminhados para o exame de ressonância magnética de corpo inteiro, sendo realizadas as sequências ponderadas em T1, T2, STIR e DWIBS. A análise e interpretação das imagens foram feitas em estações de trabalho por dois examinadores independentes, com experiência em RM e radiologia pediátrica. Resultados: Quando realizada a comparação entre os examinadores, nota-se que há alta concordância entre as quatro sequências, porém a que apresentou melhores resultados foi a STIR, com concordância perfeita entre os examinadores (Kappa=1), exceto para a pelve, que apresentou altíssimo grau de concordância (Kappa=0,816). Na avaliação do acometimento de órgãos parenquimatosos e medula óssea pelo linfoma, as quatro sequências apresentaram resultados semelhantes. Quando avaliado o acometimento de linfonodos, as sequências T1 e T2 apresentaram desempenho semelhante, porém inferior às sequências STIR e DWIBS. Conclusões: As sequências STIR e DWIBS detectaram um maior número de linfonodos caracterizados como acometidos. Todas as sequências apresentaram resultados semelhantes na avaliação dos órgãos parenquimatosos e medula óssea. Em todas as sequências analisadas houve alta concordância entre os examinadores, sendo que os melhores resultados foram obtidos na sequência STIR.
- ItemSomente MetadadadosCaracterísticas clínicas, laboratoriais e epidemiológicas do linfoma/leucemia de células T do adulto(Universidade Federal de São Paulo (UNIFESP), 1996) Borducchi, Davimar Miranda Maciel [UNIFESP]; Oliveira, José Salvador Rodrigues de [UNIFESP]
- ItemSomente MetadadadosCaracterizacao dos glicosaminoglicanos sulfatados sintetizados por celulas mononucleares de sangue periferico de pacientes portadores de neoplasias(Universidade Federal de São Paulo (UNIFESP), 1998) Soares, Liana Melo [UNIFESP]
- ItemSomente MetadadadosCaracterização imunohistoquímica dos linfomas histiocítos verdadeiros pela pesquisa de antígenos do sistema histiocítico-macrofágico(Universidade Federal de São Paulo (UNIFESP), 1986) Alberti, Vania Nose [UNIFESP]
- ItemAcesso aberto (Open Access)Classificação dos tumores hematopoéticos e linfoides de acordo com a OMS: padronização da nomenclatura em língua portuguesa, 4ª edição(Sociedade Brasileira de Patologia ClínicaSociedade Brasileira de PatologiaSociedade Brasileira de Citopatologia, 2011-12-01) Zerbini, Maria Cláudia Nogueira; Soares, Fernando Augusto; Morais, José Carlos; Vassallo, José; Velloso, Elvira Deolinda Rodrigues Pereira; Chauffaille, Maria de Lourdes Lopes Ferrari [UNIFESP]; Chiattone, Carlos Sergio; Aldred, Vera Lucia; Siqueira, Sheila Aparecida Coelho; Alves, Antonio Correa [UNIFESP]; Castelli, Jussara Bianchi; Oliveira, Claudia Regina Gomes Mendes Cardim de; Menezes, Yara de; Paes, Roberto Pinto; Universidade de São Paulo (USP); Hospital do Câncer A. C. Camargo Departamento de Anatomia Patológica; Universidade Federal do Rio de Janeiro Departamento de Patologia; Universidade Estadual de Campinas (UNICAMP); Hospital Israelita Albert Einstein Setor de Citogenética Laboratório Clínico; Universidade Federal de São Paulo (UNIFESP); Fleury Medicina Diagnóstica Laboratório de Citogenética; Santa Casa de São Paulo Faculdade de Ciências Médicas; Fleury Medicina Diagnóstica; Instituto Adolfo Lutz; Hospital Alemão Oswaldo Cruz; FCMSCSP Departamento de PatologiaINTRODUCTION: The World Health Organization (WHO) classification of hematopoietic and lymphoid tissue (4th edition, 2008) tumors constitutes an updated review of the 3rd edition published in 2001. The translation of the nomenclature used to describe the entities should be clear, precise and uniform so that clinicians, pathologists and researchers involved in the onco-hematopathological area may identify them accurately. OBJECTIVE: With this purpose, the authors present an updated proposal and a terminological standardization in Portuguese based on WHO/2008
- ItemSomente MetadadadosContribuicao da imunofenotipagem por citometria de fluxo em material de puncao aspirativa por agulha fina(PAAF) no diagnostico das doencas linfoproliferativas(Universidade Federal de São Paulo (UNIFESP), 2006) Lourenco, Carolina Escaramuzi [UNIFESP]
- ItemSomente MetadadadosHiperplasia linfoide e linfoma do tipo malt da conjuntiva: aspectos clinicos e imunopatologicos(Universidade Federal de São Paulo (UNIFESP), 2001) Ferreira, Paulo Cesar de Campos [UNIFESP]Tecido linfoide associado a mucosa (MALT) e um acumulo adquirido de celulas linfoides no estroma conjuntival, sempre associado ao epitelio. Os tumores linfoides da conjuntiva devem ser classificados como hiperplasia linfoide ou linfomas, dependendo das caracteristicas histopatologicas do infiltrado linfoide. O objetivo desta tese e, pois, analisar as caracteristicas clinica: histopatologicas e imuno-histoquimicas que permitem o diagnostico correto de tumores linfoides da conjuntiva, assim como o prognostico dessas lesoes. Os 34 casos de lesoes linfoides conjuntivais examinados foram obtidos d Registro de Patologia Ocular da Universidade McGill, em Montreal - Canada. Foram analisados os aspectos clinicos referentes a idade, sexo, cor d lesao, localizacao, lateralidade e mobilidade, assim como o estadiamento n momento do diagnostico. Preparados histopatologicos fixados em formalina e embebidos em parafina foram corados para HE, PAS e marcadores de celulas B e T. Anticorpo monoclonais para as cadeias leves de imunoglobulina k e l, foram realizado para determinar a natureza poli ou monoclonal dos tumores linfoides. Quinze dos 34 casos de infiltrados linfoides da conjuntiva representaras linfomas do tipo MALT, enquanto 19 foram diagnosticados como hiperplasia linfoide conjuntival...(au)
- ItemSomente MetadadadosImportância de marcadores celulares e moleculares no desenvolvimento e prognóstico de doenças linfoproliferativas(Universidade Federal de São Paulo (UNIFESP), 2007) Colleoni, Gisele Wally Braga [UNIFESP]; Universidade Federal de São Paulo [UNIFESP]
- ItemSomente MetadadadosLinfoma Não Hodgkin Na Criança, Adolescente E Adulto Jovem: Avaliação De Pacientes Tratados Com O Protocolo Brasileiro Do Grupo Cooperativo " Experiência Em 10 Anos De Uma Única Instituição(Universidade Federal de São Paulo (UNIFESP), 2018-04-26) Domingues, Luciana Dos Santos [UNIFESP]; Caran, Eliana Maria Monteiro [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)Introduction: Lymphomas Are Malignant Lymphoid Neoplasms And Represent The Third Most Frequent Tumor In Children. The Treatment Of These Patients In A Standardized Way, Through Cooperative Protocols, Guarantees Uniformity In Diagnosis, Greater Knowledge And Better Chances Of Cure. Objective: To Evaluate Children And Adolescents With Non- Hodgkin's Lymphoma (Nhl) Included In Gbtlnhi 2000 Protocol, Describing Clinical, Epidemiological And Survival Aspects. Methods: A Retrospective Study Was Carried Out With A Medical Charts Survey Of Nhl Patients In The Hospital Registry Sector Of Iop/ Graacc / Unifesp, Admitted From 2005 To 2015. All Patients Received Standardized Treatment Using Gbtlnhi 2000 Protocol. Results: From 2005 To 2015, 100 Cases Of Nhl Patients Who Met The Eligibility Criteria Were Admitted To The Service. The Mean Age Was 10.3 Years And The Median Age Was 9.7 Years, 81% Of The Patients Were Male. About 81.4% Of The Stage Were Advanced (Stage Iii And Iv). The Most Frequent Subtypes Were: Burkitt 60%
- ItemSomente MetadadadosLinfoma não Hodgkin na infância e adolescência(Universidade Federal de São Paulo (UNIFESP), 2004) Luisi, Flavio Augusto Vercillo [UNIFESP]; Petrilli, Antonio Sergio [UNIFESP]Introdução: O Linfoma nao Hodgkin (LNH) e a terceira neoplasia mais frequente na faixa etaria pediatrica e representa 10 por cento das doencas malignas da infancia. Objetivos: Descrever as caracteristicas do linfoma nao Hodgkin quanto ao tipo de apresentacao ao diagnostico, tratamento, evolucao clinica e fatores prognosticos; correlacionar as caracteristicas clinicas e a imuno-expressao das proteinas p53, p21, MDM2, Bcl-2, VEGF, o antigeno PCNA e o anticorpo monoclonal MIB1 (Ki-67) nos especimes tumorais com a sobrevida global e a sobrevida livre de doenca de criancas e adolescentes com linfoma nao Hodgkin. Metodos: No periodo de junho de 1988 a janeiro de 2003, foram tratados duzentos e quatro pacientes portadores de linfoma nao Hodgkin, de forma consecutiva, nao selecionada; 27 (13,23 por cento) com o protocolo LNH II 85, cento e setenta e um (83,82 por cento) com os protocolos do Grupo Brasileiro para Tratamento de Linfoma na Infancia (GBTLI) e seis (3 por cento) com outros protocolos. Dos 204 pacientes foram resgatados 90 blocos de parafina os quais possibilitaram inumeros cortes para revisao. O estudo imunoistoquimico foi realizado para os seguintes anticorpos: PCNA, p53, Ki-67, p21, Bcl2, MDM2 e VEGF. A imunoexpressao do Ki-67 e do PCNA foi avaliada quantitativamente contando-se no minimo 1000 celulas neoplasicas. A analise das laminas do p53, Bcl2, p21, MDM2 e VEGF foi realizada atraves do metodo semiquantitativo nas areas de hot spots. Resultados: A nossa casuistica mostrou que a maioria (82 por cento) dos pacientes apresentavam estadio avancado (III e IV); 61 por cento dos pacientes avaliados tinham DHL acima do normal ao diagnostico; em 51 pacientes (26 por cento) o nivel chegava ate a duas vezes o limite superior de normalidade, enquanto em 68 pacientes (35 por cento) os valores de DHL ultrapassavam duas vezes o limite superior de normalidade; o abdome (53 por cento), cabeca e pescoco (24,5 por cento), torax (14 por cento) e osso (7 por cento), foram os locais primarios mais frequentemente acometidos; houve um predominio dos linfomas de Burkitt (51,5 por cento), seguido pelos linfomas de grandes celulas (21,1 por cento) e os linfomas linfoblasticos (17,6 por cento). Conclusoes: Quase a totalidade dos pacientes (95 por cento) entrou em remissao. A sobrevida livre de doenca aos cinco anos foi de 81 por cento e a sobrevida livre de eventos de 80 por cento. Dos 31 pacientes recidivados e com falha de inducao, foram resgatados, com segundo tratamento, 10 criancas (32 por cento). Sete delas (22 por cento) estao vivas e livres de doenca. Nao houve correlacao entre as caracteristicas clinicas e a sobrevida global. As variaveis clinicas que mostraram influencia no tempo de sobrevivencia livre da doenca foram: o sitio do tumor primario, estadio e lise do tumor. Os pacientes que expressam Ki-67 maior que 66,18 por cento, tiveram maior sobrevida livre de doenca do que aqueles pacientes cuja expressao do Ki-67 foi menor que 66,18 por cento. Os pacientes que apresentaram sindrome da lise tumoral tiveram 2,8 vezes mais chances de recidivar do que pacientes que nao apresentaram lise tumoral; os pacientes que apresentaram Ki-67 menor ou igual a 66,18 por cento tem 4,2 vezes mais chance de recidivar do que pacientes que apresentaram Ki-67 maior que 66,18 por cento
- ItemAcesso aberto (Open Access)Multiple primary cutaneous plasmacytoma: first reported case in Brazil(Sociedade Brasileira de Dermatologia, 2012-08-01) Saback, Thais Lima [UNIFESP]; Botelho, Luciane Francisca Fernandes [UNIFESP]; Enokihara, Milvia Maria Simões Da Silva; Michalany, Nilceo Schwery [UNIFESP]; Floriano, Marcos César [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)Primary cutaneous plasmacytoma is a rare disease characterized by monoclonal proliferation of plasma cells in the skin, in the absence of bone or systemic disease. It can be solitary or multiple, the latter being even more rare and presenting a higher mortality rate. We describe the clinical, histopathological and immunohistochemical aspects as well as the evolution of an 87-year-old female patient, diagnosed as having multiple primary cutaneous plasmacytomas.
- ItemAcesso aberto (Open Access)Oligella urethralis isolada em hemocultura de paciente internada no complexo HSP/UNIFESP(Sociedade Brasileira de Patologia ClínicaSociedade Brasileira de PatologiaSociedade Brasileira de Citopatologia, 2009-02-01) Raimundo, Luis Gustavo [UNIFESP]; Dinato, Leandro [UNIFESP]; Pinto, Fernando Pereira [UNIFESP]; Machado, Antonia Maria De Oliveira [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)First time isolation of Oligella urethralis in two samples of peripheral blood detected by continuous metabolism monitoring methodology (Bactec 61650 system) and identified by the automatized Phoenix 61650 system (BD System) in patient with retro-peritoneal lymphoma with metastasis in the central nervous system at São Paulo hospital of Federal University of São Paulo (HSP/UNIFESP).
- ItemAcesso aberto (Open Access)O papel da expressão de Bcl-2 em material obtido por PAAF no diagnóstico de doenças linfoproliferativas B(Sociedade Brasileira de Patologia ClínicaSociedade Brasileira de PatologiaSociedade Brasileira de Citopatologia, 2008-12-01) Lourenço, Carolina Escaramuzi [UNIFESP]; Kimura, Elisa Y. S. [UNIFESP]; Sandes, Alex Freire [UNIFESP]; Alves, Antonio Correa [UNIFESP]; Colleoni, Gisele Wally Braga [UNIFESP]; Barreto, Wolney Góis [UNIFESP]; Etto, Leina Y. [UNIFESP]; Yamamoto, Mihoko [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)BACKGROUND: The diagnosis of lymphoproliferative disorders (LPD) is routinely made through histological and immunohistochemical analysis of lymph nodes. Immunophenotyping by flow cytometry (FC) is a sensitive and fast tool, which may be applied in samples obtained through fine needle aspiration for the diagnosis of LPD. Bcl-2 is a proto-oncogene that appears in several LPD and it has a significantly high expression in follicular lymphomas. OBJECTIVES: to diagnose LPD in FNA samples through morphology and flow cytometry immunophenotyping. MATERIAL AND METHODS: Samples from 25 patients with lymphadenopathies and 2 reactive tonsils were studied through morphology and immunophenotyping. The antigens expressions were evaluated by using a screening panel of monoclonal antibodies (CD3, CD4, CD8, CD19, light chains kappa; and lambda), followed by CD5, CD10, CD11c, CD23, CD79b, sIgM, FMC-7 and Bcl-2 when required. The results were compared with histology. RESULTS:Four out of 25 samples were reactive processes and 21were B-LPD. In all cases there was consistency with histological results. The mean fluorescence intensity of Bcl-2 in Follicular Lymphoma (19.92) was higher compared with other lymphoproliferative diseases (11.93) and controls (3.49) (p = 0.032). CONCLUSION: Fine needle aspiration of lymph nodes associated with cytomorphology and flow cytometry immunophenotyping allows a fast differentiation between reactive processes and B lymphoproliferative cases. The high expression of Bcl-2 by cytometry shows its usefulness in the diagnosis of the most frequent type of B-LPD. Fine needle aspiration sampling requires training and more than one aspiration is recommended.
- ItemAcesso aberto (Open Access)Perfil dos pacientes com linfoma e HIV em 5 centros da cidade de São Paulo: um estudo retrospectivo(Universidade Federal de São Paulo (UNIFESP), 2021) Vargas, Juliano Cordova [UNIFESP]; Baiocchi, Otavio Cesar Carvalho Guimaraes [UNIFESP]; http://lattes.cnpq.br/9385064975028750; http://lattes.cnpq.br/3050716643641697; Universidade Federal de São PauloIntroduction: Cancer is the leading cause of death in HIV patients in economically developed countries, even in the era of antiretroviral therapy (ART). The main cause of death in patients with HIV/AIDS, regarding the neoplastic etiology, are lymphomas. In the United States, non-Hodgkin's lymphomas are the most common cancer. Objectives: To describe the profile of patients with HIV/AIDS and who are diagnosed with concomitant lymphoproliferative diseases, in the 5 centers mentioned in this work; as well as: Assess the incidence of immune reconstitution lymphoma and identify prognostic factors for lymphoproliferative diseases and predict their respective interference in survival rates. Patients and Methods: Patients were recruited from Hospital São Paulo/UNIFESP (HSP), Instituto Emílio Ribas (IIER), Hospital Israelita Albert Einstein (HIAE), Instituto do Câncer de São Paulo (ICESP)/HC from FMUSP and Centro Paulista de Oncology (CPO), in the period from January 2000 to January 2019. Demographic data, clinical and epidemiological characteristics, laboratory tests, in addition to staging tests were obtained from patients with a confirmed anatomopathological diagnosis of Hodgkin's or non-Hodgkin's lymphoma and with a confirmed HIV diagnosis. Results Ages ranged from 17 to 79 years, with a median of 42 years, 205 (74.3%) were male and 71 (25.7%) were female. 79 (28.6%) had ECOG 0, 128 (46.4%) had ECOG 1, 38 (13.8%) had ECOG 2, 13 (4.7%) had ECOG 3, eight (2.9% ) with ECOG 4. The lymphomas were mostly of the non-Hodgkin type, present in 246 (89.2%) patients, followed by 26 (9.4%) patients with Hodgkin's Lymphoma and three (1.1%) patients with Castelman's disease. We observed that 40 (14.5%) had infiltrated bone marrow. At the time of HIV diagnosis, 93 (38.9%) patients had an undetectable viral load and 146 (61.1%) had a detectable viral load. The CD4 countgreater than 200 occurred in 117 (47%) patients, and less than 200 in 132 (53%) patients. 172 patients (63.7%) were using antiretroviral therapy. 160 (41.4%) patients had normal LDH and 150 (58.6%) had abnormal LDH. The beta 2 microglobulin, monocyte count, lymphocyte and lymphocyte-monocyte ratio had their medians estimated at 3.2, 500, 1198 and 2.5 respectively. Together, ECOG and lymphoma relapse/recurrence statistically influenced patient survival (p < 0.05), with the mortality risk of the patient with ECOG (3/4) being 2.68 times the risk of the patient with ECOG (0/1/2) and patients who experienced relapse/relapse had a mortality risk 2.15 times the risk of patients who did not experience relapse/relapse. Immune Reconstitution Lymphoma (IRI) had an incidence of 9.8%. Conclusions: In the present study, we observed a predominance of male patients, with a median age of 42 years, satisfactory ECOG, 83.7% with stage III/IV and non-Hodgkin's lymphomas. The status of the HIV virus, the CD4 lymphocyte count influenced the survival of the evaluated patients and reinforce that adequate control of the virus implies better clinical outcomes. Relapse and relapse, together, influenced patient survival. The use of rituximab does not seem to have had an impact on the response outcomes of this cohort of patients with lymphoma and HIV.
- ItemSomente MetadadadosPerfil dos pacientes onco-hematológicos do pronto socorro do Hospital São Paulo(Universidade Federal de São Paulo (UNIFESP), 2019-11-28) Jorge, Iago Farias [UNIFESP]; Riera, Rachel [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)Objectives: To develop a profile with clinical, epidemiological and laboratory data of non-critical onco-hematological patients at the Emergency Department (ED) of São Paulo’s Hospital. Methods: It’s a retrospective and observational study of oncohematological patients admitted between March 2015 and December 2017 to the Internal Medicine’s unit at the ED of São Paulo’s Hospital, located in São Paulo. The patients were selected by the medical staff on duty and the patients’ data were obtained from electronic medical records. The inclusion criteria were: being over 18 years of age, in-hospital stay of at least 48 hours and confirmed diagnosis of hematological cancer. The clinical history, vital signs and complementary exams were obtained from electronic medical records. Results: There were 22972 hospitalizations in the ED, 125 of them were of onco-hematological patients at the Internal Medicine’s unit. Men represented 53.6% of the sample and the average age was 56 years. The frequency of the main onco-hematologic diagnoses was leukemia with 38,4%, lymphoma with 36.8%, multiple myeloma with 20.8% and myelodysplastic syndrome with 4%. The main reason for hospitalizations was to treat infeccious complications, with 40% of the cases and pulmonary was the most frequent focus. It was observed that 24% of patients had creatinine levels above 1.5 mg/dL, 34% were hyponatremic, 24% were hypercalcemic and 83% of the patients had at least one cytopenia. Of the 125 patients, 16% died during the hospital stay, and all deaths were attributed to septic shock. Conclusions: Most hospitalizations of onco-hematological patients in the HSP’s ED were from men, with a mean age of 56 years. Most of these patients had disturbances in at least one vital sign or level of consciousness upon admission. One out of three patients had hyponatremia while most of them had disturbances in hematimetric indexes, with at least one cytopenia. Management of infectious complications was the most common cause of hospitalization. During this hospitalization, 16% of the patients died, and the mortality after 6, 12 and 18 months of follow-up was 36%, 46% and 50%, respectively.
- ItemSomente MetadadadosReceptor solúvel de linfócitos T humanos para eritrócitos de carneiro: dosagem por imunoeletrodifusão em soro de pacientes com hanseníase, leucemias e linfomas; comparação com dosagem sérica de proteínas da fase aguda(Universidade Federal de São Paulo (UNIFESP), 1982) Longo-Maugéri, Ieda Maria [UNIFESP]; Mendes, Nelson Figueiredo [UNIFESP]